Arcus Biosciences Announces Clinical Supply Agreement with AVEO Oncology to Evaluate Casdatifan in Combination with Tivozanib for Advanced Kidney Cancer Patients

Arcus Biosciences, Inc. (RCUS)

We couldn't retrieve the full text for this release. Read it on the company's site.